Wei Lü
Impact in
- Toxicology top 0.5%
- Bioactive Compounds and Antitumor Agents
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Cancer therapeutics and mechanisms 34
- Histone Deacetylase Inhibitors Research 14
- Protein Degradation and Inhibitors 13
-
- Click Chemistry and Applications 13
- Synthesis and biological activity 12
- Co-authors
- Jiahui Yu (40 shared papers)Yu Luo (34 shared papers)Hong Zhu (11 shared papers)Junchao Cai (12 shared papers)Stephen W. Ragsdale (5 shared papers)Yi Chen (15 shared papers)Qingqing Huang (11 shared papers)Jia Li (19 shared papers)
- Journals
- European Journal of Medicinal Chemistry (17 papers)Bioorganic & Medicinal Chemistry (16 papers)Colloids and Surfaces B Biointerfaces (14 papers)Bioorganic & Medicinal Chemistry Letters (11 papers)RSC Advances (10 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Wei Lü
236 papers receiving 4.8k citations
Peers
Comparison fields: 5 of 134
- Toxicology 219
- Biomaterials 760
- Organic Chemistry 1.4k
- Molecular Biology 2.2k
- Complementary and alternative medicine 225
Countries citing papers authored by Wei Lü
This map shows the geographic impact of Wei Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Lü more than expected).
Fields of papers citing papers by Wei Lü
This network shows the impact of papers produced by Wei Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Lü. The network helps show where Wei Lü may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Lü, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 241 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 165 | |
| 2 | 2006 | 149 | |
| 3 | 2000 | 102 | |
| 4 | 2007 | 91 | |
| 5 | 1989 | 91 | |
| 6 | 2019 | 78 | |
| 7 | 2016 | 76 | |
| 8 | 2017 | 74 | |
| 9 | 2015 | 71 | |
| 10 | 2011 | 67 | |
| 11 | 2010 | 66 | |
| 12 | 2011 | 64 | |
| 13 | 2008 | 63 | |
| 14 | 2013 | 63 | |
| 15 | 2010 | 59 | |
| 16 | 2016 | 58 | |
| 17 | 1993 | 57 | |
| 18 | 2010 | 55 | |
| 19 | 1999 | 55 | |
| 20 | 2018 | 52 |
About Wei Lü
Wei Lü is a scholar working on Molecular Biology, Organic Chemistry, Biomaterials, Oncology and Biomedical Engineering, having authored 241 papers that have together received 4.9k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (34 papers), Nanoparticle-Based Drug Delivery (33 papers), Bioactive Compounds and Antitumor Agents (18 papers), Nanoplatforms for cancer theranostics (17 papers), Histone Deacetylase Inhibitors Research (14 papers), Protein Degradation and Inhibitors (13 papers), Click Chemistry and Applications (13 papers) and Synthesis and biological activity (12 papers). The work is most often cited by research in Toxicology (219 citations), Biomaterials (760 citations), Organic Chemistry (1.4k citations), Molecular Biology (2.2k citations) and Complementary and alternative medicine (225 citations). Wei Lü has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Jiahui Yu, Yu Luo, Hong Zhu, Junchao Cai, Stephen W. Ragsdale, Yi Chen, Qingqing Huang, Jia Li, Guangrong Zheng and Bo Yang. Their work appears in journals such as European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, Colloids and Surfaces B Biointerfaces, Bioorganic & Medicinal Chemistry Letters and RSC Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.